Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device
July 21, 2023 10:35 ET
|
Positron Corp.
Niagara Falls, NY, July 21, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that...
Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device
March 01, 2023 09:37 ET
|
Positron Corp.
Niagara Falls, NY, March 01, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a molecular imaging device company that offers PET imaging systems and clinical...
Positron Corporation Announces Plans for Clinical Study of its New “Affinity PET-CT 4D” Nuclear Imaging Device
December 20, 2022 10:58 ET
|
Positron Corp.
Niagara Falls, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging systems and clinical services company, is pleased...
Positron Corporation Announces First Step in Validation of its New PET-CT Device
August 16, 2022 10:47 ET
|
Positron Corp.
Niagara Falls, NY, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is...
Positron Corporation Announces Key Sales & Services Personnel Hire
June 24, 2022 11:25 ET
|
Positron Corp.
Niagara Falls, NY, June 24, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is...
Positron Corporation Retains FDA Consulting Firm in Preparation for 510K New Device Application
February 17, 2022 14:17 ET
|
Positron Corp.
Niagara Falls, NY , Feb. 17, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is...
Positron Issues Shareholder Letter to Discuss Recent Key Highlights & 2022 Objectives
January 31, 2022 14:50 ET
|
Positron Corp.
Niagara Falls, NY, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac...
Positron Enters Long Term Cooperation Agreement with Neusoft Medical Systems for the Development and Distribution of Positron’s State of the Art PET/CT System in North America
January 18, 2022 10:00 ET
|
Positron Corp.
Niagara Falls, NY , Jan. 18, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac...
Positron Files all Financial Reports and Announces the Company is Current with its OTC Reporting & Disclosures
October 29, 2021 12:00 ET
|
Positron Corp.
Niagara Falls, NY , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging company specializing in the field of cardiac Positron...
Positron Announces Timeline for Becoming Current with its OTC Reporting & Disclosures
September 14, 2021 13:01 ET
|
Positron Corp.
Niagara Falls, NY , Sept. 14, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased to announce that Positron has received full OTCIQ access for its filing and...